Prehabilitation in Modern Colorectal Cancer Surgery: A Comprehensive Review
Abstract
:Simple Summary
Abstract
1. Introduction
2. Materials and Methods
3. The Present Concept of Prehabilitation in Surgical Management of Colorectal Cancer
3.1. Exercise Programs Used in Unimodal and Multimodal Prehabilitation
3.2. Nutritional and Psychological Interventions Used in Multimodal Prehabilitation
4. Discussion
4.1. Considerations for the Wider Use of Prehabilitation Programs in Colorectal Cancer Surgery Patients and Existing Gaps in Prehabilitation Research
4.1.1. Question 1: Which Prehabilitation Should Be Used: Multimodal or Unimodal?
4.1.2. Question 2: Is Supervised Prehabilitation Superior to the Home-Based Programs?
4.1.3. Question 3: How to Make Sure Patients Comply with Prehabilitation?
4.1.4. Question 4: When Should the Prehabilitation Be Started?
4.1.5. Question 5: What Benefits Could Prehabilitation Bring to CRC Patients?
4.2. Limitations of the Current Knowledge
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- American Cancer Society|Cancer Facts & Statistics. Available online: http://cancerstatisticscenter.cancer.org/ (accessed on 28 April 2020).
- Dulskas, A.; Kuliavas, J.; Sirvys, A.; Bausys, A.; Kryzauskas, M.; Bickaite, K.; Abeciunas, V.; Kaminskas, T.; Poskus, T.; Strupas, K. Anastomotic Leak Impact on Long-Term Survival after Right Colectomy for Cancer: A Propensity-Score-Matched Analysis. J. Clin. Med. 2022, 11, 4375. [Google Scholar] [CrossRef] [PubMed]
- Bahadoer, R.R.; Dijkstra, E.A.; van Etten, B.; Marijnen, C.A.M.; Putter, H.; Kranenbarg, E.M.-K.; Roodvoets, A.G.H.; Nagtegaal, I.D.; Beets-Tan, R.G.H.; Blomqvist, L.K.; et al. Short-Course Radiotherapy Followed by Chemotherapy before Total Mesorectal Excision (TME) versus Preoperative Chemoradiotherapy, TME, and Optional Adjuvant Chemotherapy in Locally Advanced Rectal Cancer (RAPIDO): A Randomised, Open-Label, Phase 3 Trial. Lancet Oncol. 2021, 22, 29–42. [Google Scholar] [CrossRef]
- Conroy, T.; Bosset, J.-F.; Etienne, P.-L.; Rio, E.; François, É.; Mesgouez-Nebout, N.; Vendrely, V.; Artignan, X.; Bouché, O.; Gargot, D.; et al. Neoadjuvant Chemotherapy with FOLFIRINOX and Preoperative Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer (UNICANCER-PRODIGE 23): A Multicentre, Randomised, Open-Label, Phase 3 Trial. Lancet Oncol. 2021, 22, 702–715. [Google Scholar] [CrossRef]
- Kryzauskas, M.; Bausys, A.; Degutyte, A.E.; Abeciunas, V.; Poskus, E.; Bausys, R.; Dulskas, A.; Strupas, K.; Poskus, T. Risk Factors for Anastomotic Leakage and Its Impact on Long-Term Survival in Left-Sided Colorectal Cancer Surgery. World J. Surg. Oncol. 2020, 18, 205. [Google Scholar] [CrossRef] [PubMed]
- Laursen, M.; Dohrn, N.; Gögenur, I.; Klein, M.F. Neoadjuvant Chemotherapy in Patients Undergoing Colonic Resection for Locally Advanced Nonmetastatic Colon Cancer: A Nationwide Propensity Score Matched Cohort Study. Colorectal Dis. 2022, 24, 954–964. [Google Scholar] [CrossRef] [PubMed]
- Swellengrebel, H.A.M.; Marijnen, C.A.M.; Verwaal, V.J.; Vincent, A.; Heuff, G.; Gerhards, M.F.; van Geloven, A.A.W.; van Tets, W.F.; Verheij, M.; Cats, A. Toxicity and Complications of Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer. Br. J. Surg. 2011, 98, 418–426. [Google Scholar] [CrossRef] [PubMed]
- Harriss, D.J.; Cable, N.T.; George, K.; Reilly, T.; Renehan, A.G.; Haboubi, N. Physical Activity before and after Diagnosis of Colorectal Cancer: Disease Risk, Clinical Outcomes, Response Pathways and Biomarkers. Sports Med. 2007, 37, 947–960. [Google Scholar] [CrossRef]
- Haydon, A.M.M.; Macinnis, R.J.; English, D.R.; Giles, G.G. Effect of Physical Activity and Body Size on Survival after Diagnosis with Colorectal Cancer. Gut 2006, 55, 62–67. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Northgraves, M.J. Exercise Prehabilitation in Colorectal Cancer Surgery Patients: The Effects on Physical Functioning, Health Related Quality of Life and Markers of Cellular Protection, Department of Sport, Health and Exercise Science. Ph.D. Thesis, The University of Hull, Cottingham, UK, 2016. [Google Scholar]
- Onerup, A.; Angenete, E.; Bock, D.; Haglind, E. Association between Self-Assessed Preoperative Level of Physical Activity and Postoperative Complications—An Observational Cohort Analysis within a Randomized Controlled Trial (PHYSSURG-C). Eur. J. Surg. Oncol. 2022, 48, 883–889. [Google Scholar] [CrossRef]
- Slattery, M.L. Physical Activity and Colorectal Cancer. Sports Med. 2004, 34, 239–252. [Google Scholar] [CrossRef] [PubMed]
- Adamsen, L.; Quist, M.; Andersen, C.; Møller, T.; Herrstedt, J.; Kronborg, D.; Baadsgaard, M.T.; Vistisen, K.; Midtgaard, J.; Christiansen, B.; et al. Effect of a Multimodal High Intensity Exercise Intervention in Cancer Patients Undergoing Chemotherapy: Randomised Controlled Trial. BMJ 2009, 339, b3410. [Google Scholar] [CrossRef] [Green Version]
- Singh, B.; Hayes, S.C.; Spence, R.R.; Steele, M.L.; Millet, G.Y.; Gergele, L. Exercise and Colorectal Cancer: A Systematic Review and Meta-Analysis of Exercise Safety, Feasibility and Effectiveness. Int. J. Behav. Nutr. Phys. Act. 2020, 17, 122. [Google Scholar] [CrossRef] [PubMed]
- Kraemer, M.B.; Priolli, D.G.; Reis, I.G.M.; Pelosi, A.C.; Garbuio, A.L.P.; Messias, L.H.D. Home-Based, Supervised, and Mixed Exercise Intervention on Functional Capacity and Quality of Life of Colorectal Cancer Patients: A Meta-Analysis. Sci. Rep. 2022, 12, 2471. [Google Scholar] [CrossRef] [PubMed]
- West, M.A.; Loughney, L.; Lythgoe, D.; Barben, C.P.; Sripadam, R.; Kemp, G.J.; Grocott, M.P.W.; Jack, S. Effect of Prehabilitation on Objectively Measured Physical Fitness after Neoadjuvant Treatment in Preoperative Rectal Cancer Patients: A Blinded Interventional Pilot Study. Br. J. Anaesth. 2015, 114, 244–251. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, C.; Carli, F.; Lee, L.; Charlebois, P.; Stein, B.; Liberman, A.S.; Kaneva, P.; Augustin, B.; Wongyingsinn, M.; Gamsa, A.; et al. Impact of a Trimodal Prehabilitation Program on Functional Recovery after Colorectal Cancer Surgery: A Pilot Study. Surg. Endosc. 2013, 27, 1072–1082. [Google Scholar] [CrossRef]
- Carli, F.; Charlebois, P.; Stein, B.; Feldman, L.; Zavorsky, G.; Kim, D.J.; Scott, S.; Mayo, N.E. Randomized Clinical Trial of Prehabilitation in Colorectal Surgery. Br. J. Surg. 2010, 97, 1187–1197. [Google Scholar] [CrossRef]
- Milder, D.A.; Pillinger, N.L.; Kam, P.C.A. The Role of Prehabilitation in Frail Surgical Patients: A Systematic Review. Acta Anaesthesiol. Scand. 2018, 62, 1356–1366. [Google Scholar] [CrossRef] [Green Version]
- Ottawa Hospital Research Institute. Available online: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed on 17 May 2022).
- Jadad, A.R.; Moore, R.A.; Carroll, D.; Jenkinson, C.; Reynolds, D.J.; Gavaghan, D.J.; McQuay, H.J. Assessing the Quality of Reports of Randomized Clinical Trials: Is Blinding Necessary? Control Clin. Trials 1996, 17, 1–12. [Google Scholar] [CrossRef]
- Silver, J.K.; Baima, J. Cancer Prehabilitation: An Opportunity to Decrease Treatment-Related Morbidity, Increase Cancer Treatment Options, and Improve Physical and Psychological Health Outcomes. Am. J. Phys. Med. Rehabil. 2013, 92, 715–727. [Google Scholar] [CrossRef]
- Bausys, A.; Mazeikaite, M.; Bickaite, K.; Bausys, B.; Bausys, R.; Strupas, K. The Role of Prehabilitation in Modern Esophagogastric Cancer Surgery: A Comprehensive Review. Cancers 2022, 14, 2096. [Google Scholar] [CrossRef]
- Durrand, J.; Singh, S.J.; Danjoux, G. Prehabilitation. Clin. Med. 2019, 19, 458–464. [Google Scholar] [CrossRef] [PubMed]
- Lambert, J.E.; Hayes, L.D.; Keegan, T.J.; Subar, D.A.; Gaffney, C.J. The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-Analysis. Ann. Surg. 2021, 274, 70–77. [Google Scholar] [CrossRef]
- Berkel, A.E.M.; Bongers, B.C.; Kotte, H.; Weltevreden, P.; de Jongh, F.H.C.; Eijsvogel, M.M.M.; Wymenga, M.; Bigirwamungu-Bargeman, M.; van der Palen, J.; van Det, M.J.; et al. Effects of Community-Based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery With High Risk for Postoperative Complications: Results of a Randomized Clinical Trial. Ann. Surg. 2022, 275, e299–e306. [Google Scholar] [CrossRef]
- López-Rodríguez-Arias, F.; Sánchez-Guillén, L.; Aranaz-Ostáriz, V.; Triguero-Cánovas, D.; Lario-Pérez, S.; Barber-Valles, X.; Lacueva, F.J.; Ramirez, J.M.; Arroyo, A. Effect of Home-Based Prehabilitation in an Enhanced Recovery after Surgery Program for Patients Undergoing Colorectal Cancer Surgery during the COVID-19 Pandemic. Support. Care Cancer 2021, 29, 7785–7791. [Google Scholar] [CrossRef]
- Barberan-Garcia, A.; Ubré, M.; Roca, J.; Lacy, A.M.; Burgos, F.; Risco, R.; Momblán, D.; Balust, J.; Blanco, I.; Martínez-Pallí, G. Personalised Prehabilitation in High-Risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann. Surg. 2018, 267, 50–56. [Google Scholar] [CrossRef]
- Alejo, L.B.; Pagola-Aldazabal, I.; Fiuza-Luces, C.; Huerga, D.; de Torres, M.V.; Verdugo, A.S.; Ortega Solano, M.J.; Felipe, J.L.; Lucia, A.; Ruiz-Casado, A. Exercise Prehabilitation Program for Patients under Neoadjuvant Treatment for Rectal Cancer: A Pilot Study. J. Cancer Res. Ther. 2019, 15, 20–25. [Google Scholar] [CrossRef]
- Morielli, A.R.; Usmani, N.; Boulé, N.G.; Severin, D.; Tankel, K.; Joseph, K.; Nijjar, T.; Fairchild, A.; Courneya, K.S. Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial. Clin. Colorectal Cancer 2021, 20, 216–226. [Google Scholar] [CrossRef]
- Moug, S.J.; Mutrie, N.; Barry, S.J.E.; Mackay, G.; Steele, R.J.C.; Boachie, C.; Buchan, C.; Anderson, A.S. Prehabilitation Is Feasible in Patients with Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy and May Minimize Physical Deterioration: Results from the REx Trial. Colorectal Dis. 2019, 21, 548–562. [Google Scholar] [CrossRef] [Green Version]
- Moug, S.J.; Barry, S.J.E.; Maguire, S.; Johns, N.; Dolan, D.; Steele, R.J.C.; Buchan, C.; Mackay, G.; Anderson, A.S.; Mutrie, N. Does Prehabilitation Modify Muscle Mass in Patients with Rectal Cancer Undergoing Neoadjuvant Therapy? A Subanalysis from the REx Randomised Controlled Trial. Tech. Coloproctol. 2020, 24, 959–964. [Google Scholar] [CrossRef]
- Singh, F.; Newton, R.U.; Baker, M.K.; Spry, N.A.; Taaffe, D.R.; Galvão, D.A. Feasibility and Efficacy of Presurgical Exercise in Survivors of Rectal Cancer Scheduled to Receive Curative Resection. Clin. Colorectal Cancer 2017, 16, 358–365. [Google Scholar] [CrossRef]
- Singh, F.; Galvão, D.A.; Newton, R.U.; Spry, N.A.; Baker, M.K.; Taaffe, D.R. Feasibility and Preliminary Efficacy of a 10-Week Resistance and Aerobic Exercise Intervention During Neoadjuvant Chemoradiation Treatment in Rectal Cancer Patients. Integr. Cancer Ther. 2018, 17, 952–959. [Google Scholar] [CrossRef]
- Heldens, A.F.J.M.; Bongers, B.C.; de Vos-Geelen, J.; van Meeteren, N.L.U.; Lenssen, A.F. Feasibility and Preliminary Effectiveness of a Physical Exercise Training Program during Neoadjuvant Chemoradiotherapy in Individual Patients with Rectal Cancer Prior to Major Elective Surgery. Eur. J. Surg. Oncol. 2016, 42, 1322–1330. [Google Scholar] [CrossRef]
- Loughney, L.; West, M.A.; Dimitrov, B.D.; Kemp, G.J.; Grocott, M.P.; Jack, S. Physical Activity Levels in Locally Advanced Rectal Cancer Patients Following Neoadjuvant Chemoradiotherapy and an Exercise Training Programme before Surgery: A Pilot Study. Perioper. Med. Lond. Engl. 2017, 6, 3. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gillis, C.; Fenton, T.R.; Sajobi, T.T.; Minnella, E.M.; Awasthi, R.; Loiselle, S.-È.; Liberman, A.S.; Stein, B.; Charlebois, P.; Carli, F. Trimodal Prehabilitation for Colorectal Surgery Attenuates Post-Surgical Losses in Lean Body Mass: A Pooled Analysis of Randomized Controlled Trials. Clin. Nutr. Edinb. Scotl. 2019, 38, 1053–1060. [Google Scholar] [CrossRef]
- Gillis, C.; Loiselle, S.-E.; Fiore, J.F.; Awasthi, R.; Wykes, L.; Liberman, A.S.; Stein, B.; Charlebois, P.; Carli, F. Prehabilitation with Whey Protein Supplementation on Perioperative Functional Exercise Capacity in Patients Undergoing Colorectal Resection for Cancer: A Pilot Double-Blinded Randomized Placebo-Controlled Trial. J. Acad. Nutr. Diet. 2016, 116, 802–812. [Google Scholar] [CrossRef] [PubMed]
- Furyk, C.; Senthuran, S.; Nye, D.; Ho, Y.H.; Leicht, A.S. Prehabilitation for Frail Patients Undergoing Colorectal Surgery: Lessons Learnt From a Randomised Feasibility Study. Front. Rehabil. Sci. 2021, 2, 650835. [Google Scholar] [CrossRef] [PubMed]
- Bousquet-Dion, G.; Awasthi, R.; Loiselle, S.-È.; Minnella, E.M.; Agnihotram, R.V.; Bergdahl, A.; Carli, F.; Scheede-Bergdahl, C. Evaluation of Supervised Multimodal Prehabilitation Programme in Cancer Patients Undergoing Colorectal Resection: A Randomized Control Trial. Acta Oncol. Stockh. 2018, 57, 849–859. [Google Scholar] [CrossRef] [Green Version]
- Tweed, T.T.T.; Sier, M.A.T.; Van Bodegraven, A.A.; Van Nie, N.C.; Sipers, W.M.W.H.; Boerma, E.-J.G.; Stoot, J.H.M.B. Feasibility and Efficiency of the BEFORE (Better Exercise and Food, Better Recovery) Prehabilitation Program. Nutrients 2021, 13, 3493. [Google Scholar] [CrossRef]
- de Klerk, M.; van Dalen, D.H.; Nahar-van Venrooij, L.M.W.; Meijerink, W.J.H.J.; Verdaasdonk, E.G.G. A Multimodal Prehabilitation Program in High-Risk Patients Undergoing Elective Resection for Colorectal Cancer: A Retrospective Cohort Study. Eur. J. Surg. Oncol. 2021, 47, 2849–2856. [Google Scholar] [CrossRef]
- Karlsson, E.; Farahnak, P.; Franzén, E.; Nygren-Bonnier, M.; Dronkers, J.; van Meeteren, N.; Rydwik, E. Feasibility of Preoperative Supervised Home-Based Exercise in Older Adults Undergoing Colorectal Cancer Surgery—A Randomized Controlled Design. PLoS ONE 2019, 14, e0219158. [Google Scholar] [CrossRef]
- West, M.A.; Astin, R.; Moyses, H.E.; Cave, J.; White, D.; Levett, D.Z.H.; Bates, A.; Brown, G.; Grocott, M.P.W.; Jack, S. Exercise Prehabilitation May Lead to Augmented Tumor Regression Following Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer. Acta Oncol. Stockh. 2019, 58, 588–595. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- González-Senac, N.M.; Mayordomo-Cava, J.; Macías-Valle, A.; Aldama-Marín, P.; Majuelos González, S.; Cruz Arnés, M.L.; Jiménez-Gómez, L.M.; Vidán-Astiz, M.T.; Serra-Rexach, J.A. Colorectal Cancer in Elderly Patients with Surgical Indication: State of the Art, Current Management, Role of Frailty and Benefits of a Geriatric Liaison. Int. J. Environ. Res. Public. Health 2021, 18, 6072. [Google Scholar] [CrossRef]
- Ohri, N.; Halmos, B.; Bodner, W.R.; Cheng, H.; Guha, C.; Kalnicki, S.; Garg, M.K. Daily Step Counts Predict Outcomes for Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2019, 105, E524–E525. [Google Scholar] [CrossRef] [Green Version]
- Kumar, N.B. Nutritional Management of Cancer Treatment Effects; Springer: Berlin/Heidelberg, Germany, 2012. [Google Scholar]
- Lopes, J.P.; Pereira, P.M.D.C.C.; Vicente, A.F.D.R.B.; Bernardo, A.; de Mesquita, M.F. Nutritional Status Assessment in Colorectal Cancer Patients. Nutr. Hosp. 2013, 28, 412–418. [Google Scholar] [CrossRef] [PubMed]
- Aoyagi, T.; Terracina, K.P.; Raza, A.; Matsubara, H.; Takabe, K. Cancer Cachexia, Mechanism and Treatment. World J. Gastrointest. Oncol. 2015, 7, 17–29. [Google Scholar] [CrossRef]
- Ziętarska, M.; Krawczyk-Lipiec, J.; Kraj, L.; Zaucha, R.; Małgorzewicz, S. Nutritional Status Assessment in Colorectal Cancer Patients Qualified to Systemic Treatment. Contemp. Oncol. Poznan Pol. 2017, 21, 157–161. [Google Scholar] [CrossRef] [PubMed]
- Barrera, S.; Demark-Wahnefried, W. Nutrition During and After Cancer Therapy. Oncology 2009, 23, 15–21. [Google Scholar] [PubMed]
- Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable—PubMed. Available online: https://pubmed.ncbi.nlm.nih.gov/31626055/ (accessed on 18 May 2022).
- Krebber, A.M.H.; Buffart, L.M.; Kleijn, G.; Riepma, I.C.; de Bree, R.; Leemans, C.R.; Becker, A.; Brug, J.; van Straten, A.; Cuijpers, P.; et al. Prevalence of Depression in Cancer Patients: A Meta-Analysis of Diagnostic Interviews and Self-Report Instruments. Psychooncology 2014, 23, 121–130. [Google Scholar] [CrossRef] [Green Version]
- Zhu, J.; Fang, F.; Sjölander, A.; Fall, K.; Adami, H.O.; Valdimarsdóttir, U. First-Onset Mental Disorders after Cancer Diagnosis and Cancer-Specific Mortality: A Nationwide Cohort Study. Ann. Oncol. 2017, 28, 1964–1969. [Google Scholar] [CrossRef]
- Gilligan, A.M.; Alberts, D.S.; Roe, D.J.; Skrepnek, G.H. Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. Am. J. Med. 2018, 131, 1187–1199. [Google Scholar] [CrossRef] [PubMed]
- Lu, L.; O’Sullivan, E.; Sharp, L. Cancer-Related Financial Hardship among Head and Neck Cancer Survivors: Risk Factors and Associations with Health-Related Quality of Life. Psychooncology 2019, 28, 863–871. [Google Scholar] [CrossRef] [PubMed]
- Wen, S.; Xiao, H.; Yang, Y. The Risk Factors for Depression in Cancer Patients Undergoing Chemotherapy: A Systematic Review. Support. Care Cancer 2019, 27, 57–67. [Google Scholar] [CrossRef]
- Young, K.; Singh, G. Biological Mechanisms of Cancer-Induced Depression. Front. Psychiatry 2018, 9, 299. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Waterland, J.L.; McCourt, O.; Edbrooke, L.; Granger, C.L.; Ismail, H.; Riedel, B.; Denehy, L. Efficacy of Prehabilitation Including Exercise on Postoperative Outcomes Following Abdominal Cancer Surgery: A Systematic Review and Meta-Analysis. Front. Surg. 2021, 8, 628848. [Google Scholar] [CrossRef] [PubMed]
- Husebø, A.M.L.; Karlsen, B.; Husebø, S.E. Health Professionals’ Perceptions of Colorectal Cancer Patients’ Treatment Burden and Their Supportive Work to Ameliorate the Burden—A Qualitative Study. BMC Health Serv. Res. 2020, 20, 661. [Google Scholar] [CrossRef] [PubMed]
- van Rooijen, S.; Carli, F.; Dalton, S.; Thomas, G.; Bojesen, R.; Le Guen, M.; Barizien, N.; Awasthi, R.; Minnella, E.; Beijer, S.; et al. Multimodal Prehabilitation in Colorectal Cancer Patients to Improve Functional Capacity and Reduce Postoperative Complications: The First International Randomized Controlled Trial for Multimodal Prehabilitation. BMC Cancer 2019, 19, 98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Maul, I.; Läubli, T.; Oliveri, M.; Krueger, H. Long-Term Effects of Supervised Physical Training in Secondary Prevention of Low Back Pain. Eur. Spine J. 2005, 14, 599–611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Keo, H.; Grob, E.; Guggisberg, F.; Widmer, J.; Baumgartner, I.; Schmid, J.-P.; Kalka, C.; Saner, H. Long-Term Effects of Supervised Exercise Training on Walking Capacity and Quality of Life in Patients with Intermittent Claudication. Vasa Z. Gefasskrankheiten 2008, 37, 250–256. [Google Scholar] [CrossRef]
- Rhim, H.C.; Lee, J.H.; Lee, S.J.; Jeon, J.S.; Kim, G.; Lee, K.Y.; Jang, K.-M. Supervised Rehabilitation May Lead to Better Outcome than Home-Based Rehabilitation Up to 1 Year after Anterior Cruciate Ligament Reconstruction. Med. Kaunas Lith. 2020, 57, 19. [Google Scholar] [CrossRef] [PubMed]
- Newton, R.U.; Taaffe, D.R.; Chambers, S.K.; Spry, N.; Galvão, D.A. Effective Exercise Interventions for Patients and Survivors of Cancer Should Be Supervised, Targeted, and Prescribed With Referrals From Oncologists and General Physicians. J. Clin. Oncol. 2018, 36, 927–928. [Google Scholar] [CrossRef]
- Hardcastle, S.J.; Cohen, P.A. Reply to S.C. Adams et al, C. Lopez et al, and R.U. Newton et al. J. Clin. Oncol. 2018, 36, 928–930. [Google Scholar] [CrossRef]
- Adams, S.C.; Iyengar, N.M.; Scott, J.M.; Jones, L.W. Exercise Implementation in Oncology: One Size Does Not Fit All. J. Clin. Oncol. 2018, 36, 925–926. [Google Scholar] [CrossRef] [PubMed]
- Hardcastle, S.J.; Cohen, P.A. Effective Physical Activity Promotion to Survivors of Cancer Is Likely to Be Home Based and to Require Oncologist Participation. J. Clin. Oncol. 2017, 35, 3635–3637. [Google Scholar] [CrossRef]
- Martin, L.R.; Williams, S.L.; Haskard, K.B.; Dimatteo, M.R. The Challenge of Patient Adherence. Ther. Clin. Risk Manag. 2005, 1, 189–199. [Google Scholar]
- Francis-Coad, J.; Edgar, D.; Bulsara, C.; Barrett-Lennard, A.; Owen, K.; Fletcher, D.; Wood, F.; Hill, A.-M. Partnering with Patients to Design a Prehabilitation Program for Optimizing the Patient Experience through General Surgery. Patient Exp. J. 2021, 8, 135–147. [Google Scholar] [CrossRef]
- Grimmett, C.; Bradbury, K.; Dalton, S.O.; Fecher-Jones, I.; Hoedjes, M.; Varkonyi-Sepp, J.; Short, C.E. The Role of Behavioral Science in Personalized Multimodal Prehabilitation in Cancer. Front. Psychol. 2021, 12, 634223. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Liu, Z.; Shan, F.; Ying, X.; Zhang, Y.; Li, S.; Jia, Y.; Li, Z.; Ji, J. Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. Front. Oncol. 2020, 10, 613988. [Google Scholar] [CrossRef] [PubMed]
Author; Year | Prehabilitation Group | Control Group | ||
---|---|---|---|---|
Type of Intervention (Unimodal vs. Multimodal) | Timing | Interventions Used for Prehabilitation | ||
Berkel et al. [26]; 2022 | Unimodal | Start three weeks before surgery. |
| Standard of care |
Alejo et al. [29]; 2019 | Unimodal | Start during five weeks of CRT and continuation for additional 6–8 weeks before surgery. |
| N/A |
Morielli et al. [30]; 2021 | Unimodal | Start during neoadjuvant CRT. |
| Standard of care |
West et al. [16]; 2015 | Unimodal | Start 6 weeks before surgery during neoadjuvant CRT. |
| Standard of care |
Moug et al. [31]; 2019 | Unimodal | Start before neoadjuvant CRT; a minimum of 13 weeks duration: 5 weeks during neoadjuvant CRT followed by a minimum of 8 weeks of exercises before surgery. |
| Standard of care |
Moug et al. [32]; 2020 | Unimodal | Start before neoadjuvant CRT; a minimum of 13 weeks duration: 5 weeks during neoadjuvant CRT followed by a minimum of 8 weeks of exercises before surgery. |
| Standard of care |
Singh et al. [33]; 2017 | Unimodal | Start over a period of 16 weeks before surgery. |
| N/A |
Singh et al. [34]; 2018 | Unimodal | Start over a period of 10 weeks during neoadjuvant CRT. |
| N/A |
Heldens et al. [35]; 2016 | Unimodal | Start during neoadjuvant CRT, and the exact duration depending on the individual decision for surgery timing. |
| N/A |
Loughney et al. [36]; 2017 | Unimodal | Start after completion of neoadjuvant CRT; 6-week duration. |
| Standard of care |
Gillis et al. [37]; 2019 | Multimodal | Started 4 weeks before surgery; continued 8 weeks after surgery. |
| Patients receiving rehabilitation |
Gillis et al. [38]; 2016 | Unimodal | Start 4 weeks before surgery; continued for 4 weeks after surgery. |
| Individualized nutrition counseling with a non-nutritive placebo |
Furyk et al. [39]; 2021 | Multimodal | Start 4 weeks before surgery. |
| Standard of care |
Bousquet-Dion et al. [40]; 2018 | Multimodal | Start 4 weeks before surgery. |
| Standard of care |
Tweed et al. [41]; 2021 | Multimodal | Start 4 weeks before surgery. |
| N/A |
Klerk et al. [42]; 2021 | Multimodal | Start at least 4 weeks before surgery; duration was adjusted based on the date of surgery. |
| Standard of care |
Arias et al. [27]; 2021 | Multimodal | Start 30 days before surgery; continued for 30 days after hospital discharge. |
| Standard of care |
Karlsson et al. [43]; 2019 | Unimodal | Start at least 2 weeks before surgery. |
| Standard of care |
West et al. [44]; 2019 | Unimodal | Start 6 weeks before surgery. |
| Standard of care |
Li et al. [17]; 2013 | Multimodal | The start date was predetermined by the time remaining until surgery alone. |
| Standard of care |
Author Year | Design | Description and Number of Participants (n) | Measured Outcomes | N-O Score | Jadad Score |
---|---|---|---|---|---|
Berkel et al. [26]; 2022 | RCT | Colorectal cancer patients undergoing colorectal resection (n = 57) | Primary outcome:
Secondary outcomes:
| N/A | 3 |
Alejo et al. [29]; 2019 | Non-randomized pilot study | Colorectal cancer patients undergoing neoadjuvant treatment (n = 12) | Primary outcome:
Secondary outcomes:
| 7 | N/A |
Morielli et al. [30]; 2021 | RCT | Rectal cancer patients to be treated with neoadjuvant CRT (n = 36) | Primary outcome:
Secondary outcomes:
| N/A | 3 |
West et al. [16]; 2015 | Non-randomized, blinded pilot study | Rectal cancer patients to be treated with neoadjuvant CRT (n = 39) | Primary outcome:
Secondary outcomes:
| 8 | N/A |
Moug et al. [31]; 2019 | RCT | Rectal cancer patients to be treated with neoadjuvant CRT (n = 48) | Primary outcome:
Secondary outcomes:
| N/A | 3 |
Moug et al. [32]; 2020 | RCT | Rectal cancer patients to be treated with neoadjuvant CRT (n = 44) | Primary outcome:
| N/A | 3 |
Singh et al. [33]; 2017 | Non-randomized pilot study | Rectal cancer patients planned for rectal resection (n = 12) | Primary outcome:
Secondary outcomes:
| 6 | N/A |
Singh et al. [34]; 2018 | Non-randomized pilot study | Rectal cancer patients to be treated with neoadjuvant CRT (n = 10) | Primary outcomes:
| 6 | N/A |
Heldens et al. [35]; 2016 | Non-randomized pilot study | Rectal cancer patients to be treated with neoadjuvant CRT (n = 13) | Primary outcome:
Secondary outcomes:
| 6 | N/A |
Loughney et al. [36]; 2017 | Non-randomized pilot study | Rectal cancer patients to be treated with neoadjuvant CRT (n = 39) | Primary outcome:
| 7 | N/A |
Gillis et al. [37]; 2019 | RCT | Colorectal cancer patients planned for colorectal resection (n = 139) | Primary outcomes:
| N/A | 3 |
Gillis et al. [38]; 2016 | RCT | Colorectal cancer patients planned for colorectal resection (n = 48) | Primary outcome:
Secondary outcomes:
| N/A | 3 |
Furyk et al. [39]; 2021 | RCT | Frail colorectal cancer patients planned for colorectal resection (n = 106) | Primary outcome:
Secondary outcome:
| N/A | 3 |
Bousquet-Dion et al. [40]; 2018 | RCT | Colorectal cancer patients planned for colorectal resection (n = 80) | Primary outcomes:
Secondary outcomes:
| N/A | 3 |
Tweed et al. [41]; 2021 | Non-randomized pilot study | Colorectal cancer patients planned for colorectal resection (n = 9) | Primary outcome:
Secondary outcomes:
| 6 | N/A |
Klerk et al. [42]; 2021 | Retrospective cohort study | Colorectal cancer patients planned for colorectal resection (n = 351) | Primary outcome:
Secondary outcomes:
| 8 | N/A |
Arias et al. [27]; 2021 | RCT | Colorectal cancer patients planned for colorectal resection (n = 20) | Primary outcomes:
| N/A | 3 |
Karlsson et al. [43]; 2019 | RCT | Colorectal cancer patients planned for colorectal resection (n = 23) | Primary outcome:
Secondary outcomes:
| N/A | 3 |
West et al. [44]; 2019 | Non-randomized pilot study | Colorectal cancer patients to be treated with neoadjuvant CRT (n = 35) | Primary outcomes:
| 7 | N/A |
Li et al. [17]; 2013 | Non-randomized pilot study | Colorectal cancer patients planned for colorectal resection (n = 87) | Primary outcomes:
Secondary outcomes:
| 8 | N/A |
Author; Year | Impact on Physical Status | Impact on Postoperative Outcomes | Other Effects |
---|---|---|---|
Berkel et al. [26]; 2022 | Improved VO2 at the VAT and VO2peak. Quadriceps strength also increased in the prehabilitation group. | Significantly lower complication rate vs. the usual care group. | N/A |
Alejo et al. [29]; 2019 | Improved VO2peak; after the exercise program, a tendency for increased mean levels of moderate to vigorous PA was observed. | N/A | Adherence to the program was 89% (primary outcome). The scores for the depression and the “emotional function” QoL domain were reduced in the prehabilitation group. |
Morielli et al. [30]; 2021 | Improved VO2peak while VO2peak decreased in the control group. | Prehabilitation increased rates of pCR/near pCR compared to the control group. | No significant differences were observed between groups for grade ¾ toxicities or treatment completion. |
West et al. [16]; 2015 | Improved VO2 at the VAT and VO2peak. | N/A | N/A |
Moug et al. [31]; 2019 | A reduction in step count was observed in both groups, with the prehabilitation group experiencing a lesser decline (non-significant). Prehabilitation increased 6 MWT scores (non-significant). | N/A | The prehabilitation group achieved high levels of satisfaction. |
Moug et al. [32]; 2020 | A reduction in daily step count was observed in both groups, with a more considerable reduction recorded in the control group. More patients in the intervention group achieved step count improvements at week 12. Prehabilitation increased muscle mass as determined by TPI. | N/A | N/A |
Singh et al. [33]; 2017 | Prehabilitation increased muscle strength, endurance and preserved lean body mass and ASM. | N/A | No significant changes in any QoL measure or fatigue determined by MFSI scores were reported. There were no significant changes in general well-being at any point in time (assessed using the SF-36 questionnaire) and no adverse effects or health problems related to the exercise program during the training period. |
Singh et al. [34]; 2018 | Prehabilitation significantly improved muscle strength for the lower limb exercises. While leg press endurance improved, there was no significant change in chest press muscle endurance. Physical performance as measured by 6 m fast walk and 6 m backwards walk improved in the Prehabilitation group. There was no significant change in 400-meter walk time; however, there was a substantial reduction in heart rate immediately after the completion of the test. | N/A | There were significant changes in 3 measures of QoL (emotional function, financial difficulties, diarrhea), with patients also reporting having less constipation. The exercise program did not cause any adverse events. |
Heldens et al. [35]; 2016 | Prehabilitation increased patient walking distance as determined by 6 MWT and functional exercise capacity (not significant) as well as both leg and arm muscle strength (significantly). | N/A | The feasibility and safety of the program were observed, with a very high attendance rate (95.7%). |
Loughney et al. [36]; 2017 | Significant improvements in lying down time, sleep efficiency, and duration were reported in the prehabilitation group compared to the control group.In all participants, there was a significant reduction in daily step count, EE, and MET. The apparent improvement in daily step count and overall PAL in the prehabilitation group was not statistically significant compared to the control group. | N/A | N/A |
Gillis et al. [37]; 2019 | Prehabilitation did not significantly alter body mass compared to rehabilitation. The prehabilitation group had substantially more relative and absolute LBM and less FBM than the control group. | N/A | N/A |
Gillis et al. [38]; 2016 | The prehabilitation group experienced a clinically meaningful improvement in 6 MWT scores. Recovery rates were similar between groups. No significant differences in self-reported outcomes were observed between the groups. | No significant differences were observed between the groups in an overall 30-day complications rate and severity, emergency department visits and readmission, and median length of stay. | N/A |
Furyk et al. [39]; 2021 | N/A | N/A | Poor feasibility of an RCT for preoperative prehabilitation in frail colorectal patients was reported. |
Bousquet-Dion et al. [40]; 2018 | No significant changes in 6 MWD were found between the groups; however, there was a significant correlation between physical activity, energy expenditure, and 6 MWD in the prehabilitation group. | There were no significant differences in the length of stay, emergency department visits, and complications rate between the groups. | Program compliance was 98%. |
Tweed et al. [41]; 2021 | Prehabilitation improved handgrip strength and exercise capacity. No difference was observed in VO2max and VO2 at VAT before and after prehabilitation. | N/A | No adverse effects were reported. Organizational feasibility was achieved. Overall acceptability of interventions was positive. |
Klerk et al. [42]; 2021 | Prehabilitation improved 6 MWT and 1-RM. | Compared to the standard care group, rehabilitation reduced complication rate, shortened the median stay, and patients had fewer unplanned readmissions. There was no significant difference in mortality between the groups. | N/A |
Arias et al. [27]; 2021 | Reduced the deterioration of body composition as compared to the control group 45 days after surgery. These differences, however, were attenuated at 90 days. | Prehabilitation reduced hospital stay duration and postoperative complications. | N/A |
Karlsson et al. [43]; 2019 | Prehabilitation significantly increased inspiratory muscle strength. | No significant increase in complications was observed in the prehabilitation group. The intervention group showed a shorter median length of stay and better recovery, although not statistically significant. | The recruitment rate was low, at only 35%. Compliance was much higher, at 97%. The overall intervention achieved a high level of acceptability. |
West et al. [44]; 2019 | Prehabilitation reversed the fall in VO2 at VAT due to NACRT. | The prehabilitation group had significantly greater ypTRG at the time of surgery, which did not result in a significant difference in the ypT-stage. | N/A |
Li et al. [17]; 2013 | Postoperative walking capacity improved significantly in the prehabilitation group at weeks 4 and 8. A higher share of patients recovered in the prehabilitation group compared to the standard of care at week 8. In addition, higher levels of physical activity before and after surgery were reported in the intervention group. | Similar postoperative complication rates and length of stay were observed in both groups. | Prehabilitated patients immediately before surgery had significantly decreased anxiety and depression symptoms. No clinically or statistically significant increases in any domains of HRQOL were reported for the prehabilitation group. |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bausys, A.; Kryzauskas, M.; Abeciunas, V.; Degutyte, A.E.; Bausys, R.; Strupas, K.; Poskus, T. Prehabilitation in Modern Colorectal Cancer Surgery: A Comprehensive Review. Cancers 2022, 14, 5017. https://doi.org/10.3390/cancers14205017
Bausys A, Kryzauskas M, Abeciunas V, Degutyte AE, Bausys R, Strupas K, Poskus T. Prehabilitation in Modern Colorectal Cancer Surgery: A Comprehensive Review. Cancers. 2022; 14(20):5017. https://doi.org/10.3390/cancers14205017
Chicago/Turabian StyleBausys, Augustinas, Marius Kryzauskas, Vilius Abeciunas, Austeja Elzbieta Degutyte, Rimantas Bausys, Kestutis Strupas, and Tomas Poskus. 2022. "Prehabilitation in Modern Colorectal Cancer Surgery: A Comprehensive Review" Cancers 14, no. 20: 5017. https://doi.org/10.3390/cancers14205017
APA StyleBausys, A., Kryzauskas, M., Abeciunas, V., Degutyte, A. E., Bausys, R., Strupas, K., & Poskus, T. (2022). Prehabilitation in Modern Colorectal Cancer Surgery: A Comprehensive Review. Cancers, 14(20), 5017. https://doi.org/10.3390/cancers14205017